Cases 1 - 10 of 23
Pfizer Inc. et al v. Zydus Lifesciences Ltd. et al
as 1:2024cv00316
Plaintiff:
Pfizer Inc., Global Blood Therapeutics, Inc. and PF PRISM IMB B.V.
Defendant:
Zydus Lifesciences Ltd., Zydus Worldwide DMCC and Zydus Pharmaceuticals (USA) Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Azurity Pharmaceuticals, Inc. et al v. Zydus Worldwide DMCC et al
as 1:2023cv00833
Plaintiff:
Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited
Defendant:
Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Biogen Inc. et al v. Zydus Worldwide DMCC et al
as 1:2023cv00732
Plaintiff:
Biogen Inc., Biogen Swiss Manufacturing GmbH and Alkermes Pharma Ireland Limited
Defendant:
Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Keryx Biopharmaceuticals, Inc. et al v. Zydus Worldwide DMCC et al
as 1:2023cv00331
Plaintiff:
Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc.
Defendant:
Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2023cv00266
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv01291
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv00439
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Zydus Worldwide DMCC et al
as 1:2022cv00297
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv00210
Plaintiff:
Pfizer Inc., Warner-Lambert Company LLC and PF Prism IMB B.V.
Defendant:
Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and Cadila Healthcare, Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
